EZZ Life Science Holdings Limited (ASX:EZZ)

Australia flag Australia · Delayed Price · Currency is AUD
2.330
+0.030 (1.30%)
Jun 30, 2025, 3:24 PM AEST
39.52%
Market Cap 108.50M
Revenue (ttm) 75.03M
Net Income (ttm) 9.02M
Shares Out 47.17M
EPS (ttm) 0.20
PE Ratio 11.32
Forward PE 12.99
Dividend 0.04 (1.74%)
Ex-Dividend Date May 16, 2025
Volume 19,024
Average Volume 138,669
Open 2.300
Previous Close 2.300
Day's Range 2.300 - 2.410
52-Week Range 1.290 - 4.970
Beta 0.39
RSI 59.08
Earnings Date Aug 28, 2025

About EZZ Life Science Holdings

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates through Brought in Lines and Company Owned Products segments. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers. In addition, the company engages in research, development, and sale of genomics. Further, it offers precision nutrition research products under the EZZ brand. EZZ Life Sci... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol EZZ
Full Company Profile

Financial Performance

In 2024, EZZ Life Science Holdings's revenue was 66.44 million, an increase of 78.88% compared to the previous year's 37.14 million. Earnings were 6.96 million, an increase of 91.87%.

Financial Statements

News

There is no news available yet.